Answers are grounded in this paper and cite their sources.
Successful treatment demonstrates reduced nephrotic syndrome severity in patients with fibronectin glomerulopathy, indicating potential management strategies.
Fibronectin glomerulopathy (FNG) is an autosomal dominant hereditary kidney disease caused by pathogenic variants in the FN1 gene, which encodes plasma fibronectin. Mutant fibronectin abnormally deposits within the glomerular mesangium and subendothelial regions, leading to progressive glomerular injury. FNG is typically diagnosed in young adulthood. Most patients present with asymptomatic proteinuria or chronic glomerulonephritis, while nephrotic syndrome occurs in approximately 30% of reported cases.
No takes yet. Share an insight, caveat, or question.
Shimogawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: